Pharmaceutical industry is expecting M & A boom to be created in earnest with Dream Pharma acquisition as a momentum
On July 3, Dream Pharma selected U.S. pharmaceutical company Alvogen as a preferred bidder of acquisition. Pharmaceutical industry is expecting M & A boom to be created in earnest with this acquisition as a momentum.
Meanwhile, it was estimated that the synergistic effect in accordance with merg...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
